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Abstract: COPD is associated with an increased load on the diaphragm. Since chronic muscle 
loading results in changes in antioxidant capacity and formation of reactive oxygen and reac-
tive nitrogen species, we hypothesized that COPD has a similar effect on the diaphragm, which 
is related to the severity of COPD. Catalase activity was determined spectrophotometrically. 
Levels of 4-hydroxy-2-nonenal (HNE)-protein adducts and 3-nitrotyrosine (NT) formation 
were measured using western blotting. Levels of malondialdehyde (MDA) were assessed by 
high-performance liquid chromatography. We found that catalase activity was ~89% higher in 
the diaphragm of severe COPD patients (FEV1 37 ± 5% predicted) compared with non-COPD 
patients. MDA levels, a marker for lipid peroxidation, were signiﬁ  cantly lower in the diaphragm 
of COPD patients compared with non-COPD patients, whereas the level of HNE-protein adducts 
was equal in both groups. NT formation was not different between groups. However, increas-
ing hyperinﬂ  ation and NT formation were inversely correlated. These results indicate that in 
COPD the diaphragm adapts to a higher work load by increasing catalase activity, resulting in 
a reduction in oxidative damage to lipids and tyrosine nitration of proteins.
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Introduction
In patients with COPD, the diaphragm is exposed to a chronically increased work load, 
due to several factors including airﬂ  ow obstruction and geometrical changes of the 
thorax derived from pulmonary hyperinﬂ  ation. As a result, several adaptations occur 
in diaphragm muscle, eg, a shift towards type I ﬁ  bers, an increase in oxidative enzyme 
activity (Levine et al 2002), loss of ﬁ  ber myosin heavy chain content, and reduced in 
vitro force generation (Ottenheijm et al 2005).
In rat diaphragm, in vitro studies have shown that the production of reactive oxy-
gen species (ROS) is enhanced with increased contractile activity (Reid, Haack, et 
al 1992; Reid, Shoji, et al 1992; Kolbeck et al 1997). ROS are required for optimal 
contractile function (Reid, Haack, et al 1992), but overproduction of ROS may result in 
a disturbance between the pro-oxidant and antioxidant balance in favor of the former. 
The resulting so-called oxidative stress is associated with impaired force generation 
of skeletal and respiratory muscle in animal models (Kolbeck et al 1997; Reid, Shoji, 
et al 1992). In line with these observations, in vitro force generation of the emphyse-
matous hamster diaphragm is inversely correlated with glutathione oxidation in the 
diaphragm (Heunks et al 2000).
Oxidative stress has been implicated in the involvement in muscle dysfunction of 
the quadriceps of COPD patients (Barreiro et al 2003). When a muscle is chronically 
exposed to oxidants, which can be hypothesized to occur in the diaphragm of patients 
with COPD, it may be expected that this chronic exposure provokes an increase in 
antioxidant defense. Whether this occurs in the diaphragm of patients with COPD 
is unknown. However, exercise training in healthy subjects, a condition known to International journal of COPD 2006:1(2) 174
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enhance skeletal muscle ROS generation, has been shown 
to upregulate skeletal muscle antioxidant enzymes including 
superoxide dismutase (Zidoni and Kremer 1974).
In addition to ROS, nitric oxide (NO) has been shown to 
modulate muscle performance (for a review, see Reid 2001). 
NO is produced in skeletal muscle ﬁ  bers by NO synthases 
(NOS). The main source of NO synthesis is the neuronal 
(nNOS) isoform, which is localized in close proximity to 
the sarcolemma (Kobzik et al 1994). There is increasing 
evidence that NO plays a role in regulating muscle glucose 
uptake (Roy et al 1998), sarcoplasmic Ca2+ release (Suko 
et al 1999), and blood ﬂ  ow (Hickner et al 1997). Excessive 
NO production inside skeletal muscle ﬁ  bers, however, exerts 
deleterious effects on sarcolemmal integrity and contractile 
function (Stamler and Meissner 2001). NO can react with the 
superoxide anion (·O2
–) to form the highly reactive oxidant 
peroxynitrite (·ONOO) (for a review see Beckman and Kop-
penol 1996). Peroxynitrite modiﬁ  es protein tyrosine residues 
to create 3-nitrotyrosine (NT).
Recently, Barreiro et al (2005) observed increased oxi-
dative stress as measured by 4-hydroxy-2-nonenal (HNE) 
levels and protein carbonyl groups, but unchanged 3-NT 
levels in the diaphragm of moderate and severe COPD pa-
tients. In contrast, in a pilot report (Wijnhoven et al 2004) 
we showed that NT levels were higher in the diaphragm of 
COPD patients, whereas the level of HNE was not changed. 
The present study extended the data of this pilot study. Spe-
ciﬁ  cally, we hypothesized that in the diaphragm of COPD 
patients: (1) The activity of antioxidant enzymes is increased; 
(2) Indirect markers for ROS production and reactive nitro-
gen species (RNS) production are elevated; and (3) These 
changes are related to the severity of hyperinﬂ  ation. To test 
these hypotheses, we determined catalase activity as a marker 
for antioxidative capacity, levels of lipid peroxidation as a 
marker for oxidative stress, and NT formation as a marker 
for RNS production.
Methods
Subjects
Diaphragm muscle biopsies were obtained from subjects 
undergoing thoracotomy for lung cancer or lung volume 
reduction surgery. These patients were divided into 3 groups:
non-COPD (n = 15; mean FEV1 = 110 ± 3 % predicted), 
mild-to-moderate COPD (n = 17; mean FEV1 = 67 ± 3% 
predicted). and severe COPD (n = 7; mean FEV1 = 37 ± 5% 
predicted). General characteristics and pulmonary function 
data are shown in Table 1. Informed consent was obtained 
from each of the subjects, and the study was approved by 
the ethical committee of our hospital.
Biopsy handling
Biopsies were immediately cut into 2 pieces. One part 
was directly frozen in liquid nitrogen for biochemical 
determinations. The remaining part was directly frozen 
in isopentane precooled by liquid nitrogen for immuno-
histochemistry. Both samples were stored at –80°C until 
further analysis. Due to limitation of the biopsy size, all 
the biochemical determinations could not be performed in 
each patient.
Catalase activity determination
Fresh frozen biopsies were thawed in ice-cooled buffer 
containing 250 mM sucrose, 2 mM EDTA, and 10 mM 
Tris-HCl (pH 7.4). In this buffer muscle homogenates 
(5% wt/vol) were prepared using a Potter-Elvehjem glass-
teﬂ  on homogenizer. The catalase activity was measured using 
the method of Aebi (1984). Brieﬂ  y, the above-mentioned 
homogenates were used, and H2O2 decomposition was 
measured spectrophotometrically. The difference in absorb-
ance (ΔA240) per minute was a measure of the catalase activity. 
The assay was performed in duplicate.
Immunoblotting
NT formation was detected using western immunoblotting 
with a monoclonal anti-NT antibody (clone 1A6; Upstate 
Table 1 Patient characteristics
   Mild-to-moderate 
  Non-COPD  COPD   Severe COPD
 (n = 15) (n = 17)   (n = 7)
Age (years)  58 ± 3 63 ±V2 59 ± 4
BMI (kg/m2) 25 ± 1 26 ± 1 23 ± 1
FEV1   3.30 ± 0.13 1.91 ± 0.09 aa  1.12 ± 0.19 aa bb
FEV1 % predicted  110 ± 3 67 ± 3 aa  37 ± 5 aa bb
FEV1/VC 78 ± 1 53 ± 2 aa  33 ± 5 aa bb
TLC % predicted  103 ± 3 90 ± 5 114 ± 8 b
FRC % predicted  98 ± 19 93 ± 6 130 ± 15 b
KCO % predicted  95 ± 6 76 ± 4 a  48 ± 8 aa b
Values are means ± SEM.
a p < 0.05 and aa p < 0.001 vs non-COPD patients.
b p < 0.05 and bb p < 0.001 between mild-to-moderate COPD and severe 
COPD patients.
Abbreviations: BMI, body mass index; FEV1, forced expiratory volume 
in 1 second; VC, vital capacity; TLC, total lung capacity; KCO, diffusion 
coefﬁ  cient for carbon monoxide; FRC, functional residual capacity.International Journal of COPD 2006:1(2) 175
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Biotechnology Inc, Lake Placid, NY, USA), as published 
previously (Zhu et al 2005). Brieﬂ  y, crude muscle homoge-
nate proteins (10 μg) were separated by electrophoresis (100 V 
for 1 hour) on 10% sodium dodecylsulfate polyacrylamide 
gels. Proteins were transferred electrophoretically (100 V, 
300 mA for 1.5 hours) to nitrocellulose membranes. The 
nitrocellulose membranes were subsequently incubated with 
primary monoclonal antibodies against NT. After a washing 
step, the nitrocellulose membranes were incubated with a 
secondary antibody (polyclonal anti-mouse IgG horseradish 
peroxidase conjugated; Pierce, Rockford, IL, USA). After a 
second washing step, protein bands were visualized using 
an enhanced chemiluminescence detection kit (Amersham 
Biosciences Europe GmbH, The Netherlands). The blots 
were scanned with an imaging densitometer and optical 
densities (OD) of positive NT protein bands were quanti-
ﬁ  ed with GeneTools software (Syngene, UK). Total NT OD 
was calculated for each sample by adding OD of individual 
positive protein bands.
HNE was detected with the same method as NT, with 
a few alterations. The primary antibody was a polyclonal 
rabbit antibody against 4-hydroxy-2-nonenal (Calbiochem, 
San Diego, CA, USA). The secondary antibody was a 
polyclonal anti-rabbit IgG antibody (polyclonal anti-rabbit 
IgG horseradish peroxidase conjugated; Pierce, Rockford, 
IL, USA).
Immunohistochemistry
A polyclonal rabbit antibody against 4-hydroxy-2-nonenal 
used (Calbiochem, San Diego, CA, USA). NT was detected 
with a polyclonal rabbit anti-NT antibody (Upstate 
Biotechnology Inc., Lake Placid, NY, USA). Tissue 
sections (5 μm) were incubated with the antibodies in 0.5% 
(w/v) BSA in PBS with 0.05% Tween-20 (BSA/PBST) 
for 60 minutes. Bound antibodies were detected using 
Alexa-labelled (488) anti-rabbit antibodies. Finally, tissue 
sections were ﬁ  xed in methanol, air-dried, and embedded 
in mowiol (10% [w/v] in 0.1 M Tris-HCl, pH 8.5, 25% [v/v] 
glycerol), and 2.5% [w/v] NaN3). As a control, primary 
antibodies were omitted.
Malondialdehyde determination
Malondialdehyde (MDA) levels were assessed by high-
performance liquid chromatography, as previously reported 
(Wong et al 1987; Zhu et al 2005). Muscle samples (40 mg) 
were homogenized and centrifuged, and the supernatants 
were collected and stored on ice. Samples were hydrolyzed 
by boiling in diluted phosphoric acid. MDA, one of 
the low-molecular-weight end products formed via the 
decomposition of lipid-peroxidation products, was reacted 
with thiobarbituric acid (TBA) to form MDA-TBA adducts 
(Janero 1990). The adduct was eluted from the column with 
methanol-phosphate buffer and quantiﬁ  ed spectrophoto-
metrically at 532 nm.
Statistical analysis
Data are presented as mean ± standard error of the mean 
(SEM) when appropriate. Data were analyzed with SPSS 
for Windows®, version 12.0.1. A oneway ANOVA test was 
used to compare results between groups. To establish the 
relationship between the oxidative stress parameters and lung 
function, Pearson correlation was determined. Signiﬁ  cance 
was set at the 0.05 level.
Results
Patient characteristics
Patient characteristics are shown in Table 1. The patients 
with COPD did not differ signiﬁ  cantly from the non-
COPD patients with respect to age and body mass index 
(BMI).
Catalase activity
Diaphragm muscle catalase activity was significantly 
higher in severe COPD patients (n = 3) compared with both 
non-COPD patients (n = 5) and with patients with mild-
to-moderate COPD (n = 5) (Figure 1).
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Figure 1 Catalase activity (mean ± SEM) in diaphragms of non-COPD patients and 
both mild-to-moderate and severe COPD patients. Catalase activity was signiﬁ  -
cantly elevated in the diaphragm of severe COPD patients.
ap < 0.05 vs non-COPD patients; bp < 0.05 vs mild-to-moderate COPD patients.International journal of COPD 2006:1(2) 176
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NT formation
Diaphragm muscle NT level was assessed as a marker 
for peroxynitrite formation. As illustrated in Figure 2, no 
difference was found in muscle protein nitration between 
the groups (non-COPD: n = 7, mild-to-moderate COPD: 
n = 6, severe COPD: n = 3). Among all COPD patients, sig-
niﬁ  cant negative correlations were found between muscle 
protein nitration and total lung capacity (TLC) (r = –0.797, 
p = 0.018), TLC% predicted (r = –0.85, p = 0.007), and 
FRC% predicted (r = –0.85, p = 0.008). Immunoﬂ  uorescence 
analysis showed positive staining for NT localized within 
the muscle ﬁ  bers in both COPD patients and non-COPD 
patients, with some ﬁ  bers staining more intensely than 
other ﬁ  bers (Figure 3).
Lipid peroxidation
Figure 4 shows the effect of COPD on markers for lipid 
peroxidation in the diaphragm. HNE-protein adduct 
formation was not signiﬁ  cantly different between severe 
COPD (n = 2), mild-to-moderate COPD (n = 6), and non-
COPD patients (n = 7). No relationship was found between 
HNE-protein adducts and severity of hyperinﬂ  ation in 
the COPD group. Immunoﬂ  uorescence analysis showed 
positive staining for HNE-protein adducts localized within 
the muscle ﬁ  bers in both COPD patients and non-COPD 
patients (Figure 5).
Diaphragm MDA level was signiﬁ  cantly lower in mild-
to-moderate COPD patients (n = 6) compared with non-COPD 
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Figure 2 (a) 3-Nitrotyrosine (NT) optical density (OD) (mean ± SEM) in dia-
phragms of non-COPD patients and both mild-to-moderate and severe COPD 
patients. NT levels were not different between the three groups. 
(b) Relationship between total lung capacity (TLC) % predicted and NT OD in all 
COPD patients (r = –0.853, p = 0.007).
Figure 3 Immunoﬂ  uorescence analysis of 3-nitrotyrosine localization in diaphragm muscle of 1 representative non-COPD patient (a) and 1 representative severe COPD 
patient (b). The staining is localized diffusely within the muscle ﬁ  bers, with some ﬁ  bers staining more intensely than other ﬁ  bers. Scale bar = 100 μm.International Journal of COPD 2006:1(2) 177
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patients (n = 3). MDA level in severe COPD patients (n = 2) 
tended to be lower than in non-COPD patients.
Discussion 
Our results demonstrate that in the diaphragm of COPD 
patients, catalase activity is increased and lipid peroxida-
tion is decreased. Furthermore, with increasing severity 
of hyperinﬂ  ation, the level of protein tyrosine nitration is 
reduced.
Oxidative and nitrosative stress may be expected to occur 
in the diaphragm of COPD patients. Firstly, antioxidative 
capacity may be altered. In this study, we found that the 
activity of catalase is increased in the diaphragm of COPD 
patients. This ﬁ  nding is in accordance with the increase in 
diaphragmatic antioxidant capacity after endurance training 
in rats (Vincent et al 1999) and mice (Salminen and Vihko 
1983), and in line with progressive endurance training of the 
human diaphragm due to increased load over several decades 
(Levine et al 2001). Barreiro et al (2005) reported a tendency 
towards a decrease in catalase protein content with increasing 
severity of hyperinﬂ  ation. However, catalase protein content 
is not directly related to catalase activity (Wilson and Johnson 
2000), so our ﬁ  ndings do not necessarily contrast with the 
ﬁ  ndings by Barreiro et al.
Secondly, alterations in the level of nitrotyrosines, a 
marker for peroxynitrite generation, may occur. Peroxyni-
trite is a reaction product of NO and ·O2
–. In contrast to our 
hypothesis, NT level was decreased with increasing severity 
of hyperinﬂ  ation. In rat gastrocnemius muscle, endurance 
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Figure 4 (a) 4-Hydroxy-2-nonenal (HNE) optical density (OD) (mean ± SEM) in 
diaphragms of non-COPD patients and both mild-to-moderate and severe COPD 
patients. HNE-protein adduct levels were not different between the three groups. 
(b) Malondialdehyde (MDA) levels (mean ± SEM) in diaphragms of non-COPD 
patients and both mild-to-moderate and severe COPD patients. MDA levels were 
signiﬁ  cantly lower in diaphragms of mild-to-moderate COPD patients (ap < 0.05) 
and tended to be lower in severe COPD patients (p = 0.06).
Figure 5 Immunoﬂ  uorescence analysis of 4-hydroxy-2-nonenal-protein adduct localization in diaphragm muscle of 1 representative non-COPD patient (a) and 1 repre-
sentative severe COPD patient (b). The staining is localized diffusely within the muscle ﬁ  bers, with some ﬁ  bers staining more intensely than other ﬁ  bers. Scale bar = 100 μm.International journal of COPD 2006:1(2) 178
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training increases NT formation (Vassilakopoulos et al 2003). 
A possible explanation is that the activity of, eg superoxide 
dismutase (SOD), may also be increased in the diaphragm 
of COPD patients, since training-induced increases in SOD 
activity have been reported in rat vastus lateralis (Leeuwen-
burgh et al 1994, 1997). This increase might decrease levels 
of ·O2
–, leading to decreased peroxynitrite formation and 
thus lower NT levels.
Another consequence of an alteration in redox state that 
may occur in the diaphragm of COPD patients, is a change 
in lipid peroxidation. In this study, we found a decreased 
level of MDA in the diaphragm of COPD patients, but no 
change in HNE-protein adduct formation, which is most 
likely related to the small sample size. The determination 
of MDA and HNE are different methods, based on dif-
ferent principles. HNE is recognized as the most reliable 
marker of lipid peroxidation (Uchida and Stadtman 1992; 
Toyokuni et al 1995), but the number of measurements 
in severe COPD patients was low. For determination of 
MDA, we used a speciﬁ  c, sensitive, and reproducible 
HPLC method that allows a good separation between the 
MDA-TBA and interfering substances (Wong et al 1987). 
The reduced MDA levels observed in our study strongly 
indicate that enhanced lipid peroxidation occurs in the 
diaphragm of COPD patients. Since the diaphragm of 
COPD patients shows endurance training-like alterations 
(Levine et al 2002), we suggest that the lower level of 
lipid peroxidation also resembles the effect of endurance 
training. Indeed, the decreased level of lipid peroxidation 
in our study is in accordance with studies in skeletal mus-
cle after endurance training in mice (Salminen and Vihko 
1983) and in diaphragm muscle of endurance-trained rats 
(Vincent et al 1999).
In contrast to the reduced lipid peroxidation in dia-
phragm muscle of COPD patients, lipid peroxidation seems 
to be increased in peripheral muscle of COPD patients. For 
example, Allaire et al (2002) found an increase in lipofuscin 
content, a marker for oxidative damage to lipids, in quadri-
ceps muscle of COPD patients. This ﬁ  nding contrasts with 
those of other studies (Rabinovich et al 2001; Couillard et al 
2003), reporting equal levels of lipid peroxidation in vastus 
lateralis muscle of resting COPD patients as compared with 
controls, evaluated by the concentration of thiobarbituric 
acid reactive substances (TBARs). This discrepancy may 
be explained by different methods that were used to assess 
lipid peroxidation; whereas TBARs are markers of acute 
oxidative stress, lipofuscin, which accumulates in the cells, 
is a reﬂ  ector of cumulative stress. Moreover, the latter study 
(Couillard et al 2003) reported an increase in lipid peroxi-
dation after an exercise bout in vastus lateralis of COPD 
patients. Furthermore, glutathione peroxidase activity in 
vastus lateralis muscle of healthy subjects was increased 
after a single bout of exercise, whereas the antioxidant 
activity of COPD patients was not changed. This indicates 
that vastus lateralis muscle of COPD patients is more vul-
nerable to oxidative stress as a result of a compromised 
exercise-induced increase in antioxidative function. Besides 
determination of lipid peroxidation in the muscle, plasma 
lipid peroxidation can be used as a marker for free radical-
induced tissue damage. We (Heunks et al 1999) reported 
previously that in rest there was no difference in serum MDA 
level between COPD patients receiving the xanthine oxidase 
inhibitor allopurinol and control COPD patients. However, 
after exhaustive exercise, MDA levels were signiﬁ  cantly 
higher in the control COPD subjects, suggesting that during 
exercise lipid peroxidation occurs, which can be attenuated 
by treatment with allopurinol.
In the diaphragm of COPD patients a shift occurs from 
type II to type I ﬁ  bers (Levine et al 1997) and it has been 
previously shown that type I ﬁ  bers are more susceptible to 
lipid peroxidation (Allaire et al 2002). However, in our study 
we have shown decreased lipid peroxidation levels in the 
diaphragm of COPD patients. This might be explained by 
the ﬁ  nding that antioxidative capacity is increased, thereby 
protecting the muscle ﬁ  bers against lipid peroxidation. In 
contrast, in peripheral muscles of COPD patients a shift 
occurs towards type II ﬁ  bers (Maltais et al 1996; Whittom 
et al 1998; Gosker et al 2002), having a lower antioxidant 
capacity than type I ﬁ  bers (Caillaud et al 1999; Ji et al 1992). 
This may explain the fact that in peripheral skeletal muscles 
of COPD patients more lipid peroxidation is observed, 
although the exact relationship between ﬁ  ber type com-
position and antioxidant capacity remains to be elucidated 
in COPD. These ﬁ  ndings together suggest that the disuse 
of peripheral muscles in COPD results in enhanced lipid 
peroxidation, whereas the chronically increased loading 
on the diaphragm in COPD results in a decrease in lipid 
peroxidation.
In summary, this study shows that in the diaphragm of 
COPD patients, catalase activity as a marker for antioxidant 
capacity is increased, associated with a decrease in oxida-
tive and nitrosative stress. From a clinical perspective, this International Journal of COPD 2006:1(2) 179
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adaptation may be beneﬁ  cial for diaphragm function, as 
it has been shown that oxidative stress is associated with 
muscle dysfunction.
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